| Authors: |
Park CL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Dinstag G; Pangea Biomed, Tel Aviv, Israel., Lopes CDH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Strum S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Bruce JP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Tirosh O; Pangea Biomed, Tel Aviv, Israel., Dhruba SR; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Hoang DT; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Beker T; Pangea Biomed, Tel Aviv, Israel., Shulman E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Genta S; Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada., Razak ARA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Ruppin E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Translational Research Institute and Jim and Eleanor Randall Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Aharonov R; Pangea Biomed, Tel Aviv, Israel., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. lillian.siu@uhn.ca. |
